Search research articles
Contact Us
Filters
Showing results (81-90 of 142) with videos related to
Page
of 15
Sort By:
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2018
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1
Junpeng Qi, Xiuling Li, Haiyong Peng, et al.
Restorative Neurology and Neuroscience
|
September 30, 2008
Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems
Roman J Giger, Karthik Venkatesh, Onanong Chivatakarn, et al.
Journal of Medicinal Chemistry
|
October 29, 2004
Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices
Lian-Sheng Li, Christoph Rader, Masayuki Matsushita, et al.
Current Protocols in Cell Biology
|
February 11, 2014
Analysis of cell-cell contact mediated by Ig superfamily cell adhesion molecules
Esther T Stoeckli, Devrim Kilinc, Beat Kunz, et al.
Cell Chemical Biology
|
June 25, 2019
Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues
Dobeen Hwang, Napon Nilchan, Alex R Nanna, et al.
Plos One
|
January 4, 2013
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies
Hema Dave, Miriam R Anver, Donna O Butcher, et al.
Journal of Medicinal Chemistry
|
January 4, 2023
Application of a Biocatalytic Strategy for the Preparation of Tiancimycin-Based Antibody-Drug Conjugates Revealing Key Insights into Structure-Activity Relationships
Andrew D Steele, Alexander F Kiefer, Dobeen Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells
Michael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.
Blood
|
August 12, 2009
A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display
Sivasubramanian Baskar, Jessica M Suschak, Ivan Samija, et al.
Cancer Immunology Research
|
September 13, 2014
The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity
Michael Hudecek, Daniel Sommermeyer, Paula L Kosasih, et al.
Page
of 15
Search research articles
Search
Showing results (81-90 of 142) with videos related to
Sort By:
Page
of 15
Proceedings of the National Academy of Sciences of the United States of America
|
May 31, 2018
Potent and selective antitumor activity of a T cell-engaging bispecific antibody targeting a membrane-proximal epitope of ROR1
Junpeng Qi, Xiuling Li, Haiyong Peng, et al.
Restorative Neurology and Neuroscience
|
September 30, 2008
Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems
Roman J Giger, Karthik Venkatesh, Onanong Chivatakarn, et al.
Journal of Medicinal Chemistry
|
October 29, 2004
Chemical adaptor immunotherapy: design, synthesis, and evaluation of novel integrin-targeting devices
Lian-Sheng Li, Christoph Rader, Masayuki Matsushita, et al.
Current Protocols in Cell Biology
|
February 11, 2014
Analysis of cell-cell contact mediated by Ig superfamily cell adhesion molecules
Esther T Stoeckli, Devrim Kilinc, Beat Kunz, et al.
Cell Chemical Biology
|
June 25, 2019
Site-Selective Antibody Functionalization via Orthogonally Reactive Arginine and Lysine Residues
Dobeen Hwang, Napon Nilchan, Alex R Nanna, et al.
Plos One
|
January 4, 2013
Restricted cell surface expression of receptor tyrosine kinase ROR1 in pediatric B-lineage acute lymphoblastic leukemia suggests targetability with therapeutic monoclonal antibodies
Hema Dave, Miriam R Anver, Donna O Butcher, et al.
Journal of Medicinal Chemistry
|
January 4, 2023
Application of a Biocatalytic Strategy for the Preparation of Tiancimycin-Based Antibody-Drug Conjugates Revealing Key Insights into Structure-Activity Relationships
Andrew D Steele, Alexander F Kiefer, Dobeen Hwang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 27, 2013
Receptor affinity and extracellular domain modifications affect tumor recognition by ROR1-specific chimeric antigen receptor T cells
Michael Hudecek, Maria-Teresa Lupo-Stanghellini, Paula L Kosasih, et al.
Blood
|
August 12, 2009
A human monoclonal antibody drug and target discovery platform for B-cell chronic lymphocytic leukemia based on allogeneic hematopoietic stem cell transplantation and phage display
Sivasubramanian Baskar, Jessica M Suschak, Ivan Samija, et al.
Cancer Immunology Research
|
September 13, 2014
The nonsignaling extracellular spacer domain of chimeric antigen receptors is decisive for in vivo antitumor activity
Michael Hudecek, Daniel Sommermeyer, Paula L Kosasih, et al.
Page
of 15